ReWalk Unveils Soft Suit Exoskeleton for Stroke Patients
“Restore” NextGen Exoskeleton System Developed in Collaboration with Harvard’s Wyss Institute
MARLBOROUGH, MA / YOKNEAM ILIT, ISRAEL – June 19, 2017 – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), leading manufacturer of exoskeleton systems, premiered the prototype for a soft suit exoskeleton intended to assist stroke survivors on Yahoo Finance.
ReWalk CEO Larry Jasinski was joined by collaborators from Harvard University’s Wyss Institute for Biologically Inspired Engineering to showcase the prototype, called Restore, and demonstrate how the system works. ReWalk announced a focus on the development of the soft suit as a core company goal for FY2017.
“We are thrilled with the progress of the Restore system, which will provide life changing technology to a whole new class of patients facing mobility issues,” said Jasinski. “With the prototype finished, we are eager to begin clinical studies and pursue regulatory approvals so that these systems can be provided to millions of patients who can benefit from access to the device.”
ReWalk is working with the Wyss Institute on the development of lightweight designs to complete clinical studies, pursue regulatory approvals and commercialize the systems on a global scale. The first commercial application will be for stroke survivors, followed by Multiple Sclerosis patients and then additional applications. There are an estimated 3 million stroke survivors with lower limb disability in the U.S.
How It Works: the Restore transmits power to key joints of the legs with cable technologies, powered with software and mechanics that are similar to the technologies used in the ReWalk exoskeleton system for individuals with spinal cord injury. The cables are connected to fabric-based designs that attach to the legs and foot, thus lending the name “soft suit.”
Anticipated delivery of a commercial Restore soft suit is slated for 2018.
Watch the Yahoo Finance segment here.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. Our mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel.